Geron | GERN - Kapitał Własny I Rezerwy





Kapitał Własny I Rezerwy Zmiana Data
Amgen USD 11.69B 2.5B 2026-06
Bio Techne USD 2.11B 22.92M 2026-06
Cassava Sciences USD 68.14M 6.26M 2026-03
Cytokinetics USD -173.49M 653.08M 2026-06
Exelixis USD 1.84B 91.99M 2026-06
Genmab DKK 5.96B 275M 2026-06
Geron USD 218.61M 10.49M 2026-06
Gilead Sciences USD 11.74B 11.77B 2026-06
Incyte USD 6.34B 721.58M 2026-06
MacroGenics USD 42.87M 21.68M 2026-06
Novartis USD 41.95B 3.02B 2026-06
Novavax USD -190.71M 45.94M 2026-06